Skip to main content

Advertisement

Log in

Re: Controversies—[Tc(CO)3]+ chemistry: a promising new concept for SPET?

  • Letter to the Editor
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Alberto R. [Tc(CO)3]+ chemistry: a promising new concept for SPET? For. Eur J Nucl Med Mol Imaging 2003; 30:1299–1302.

    Article  PubMed  Google Scholar 

  2. Welch MJ, Lewis JS. [Tc(CO)3]+ chemistry: a promising new concept for SPECT? Against. Eur J Nucl Med Mol Imaging 2003; 30:1302–1304.

    Article  PubMed  Google Scholar 

  3. Guo W, Hinkle GH, Lee RJ. 99mTc-HYNIC-folate: a novel receptor-based targeted radiopharmaceutical for tumor imaging. J Nucl Med 1999; 40:1563–1569.

    PubMed  Google Scholar 

  4. Liu S, Harris AR, Williams NE, Edwards DS. 99mTc-labeling of a hydrazinonicotinamide-conjugated LTB(4) receptor antagonist useful for imaging infection and inflammation. Bioconjug Chem 2002; 13:881–886.

    Article  PubMed  Google Scholar 

  5. Schibli R, Schubiger PA. Current use and future potential of organometallic radiopharmaceuticals. Eur J Nucl Med Mol Imaging 2002; 29:1529–1542.

    Article  PubMed  Google Scholar 

  6. Egli A, Alberto R, Tannahill L, Schibli R, Abram U, Schaffland A, Waibel R, Tourwé D, Jeannin L, Iterbeke K, Schubiger PA. Organometallic 99mTc-aquaion labels peptide to an unprecedented high specific activity. J Nucl Med 1999; 40:1913–1917.

    CAS  PubMed  Google Scholar 

  7. Ballinger JR. The effect of carrier on technetium-99m radiopharmaceuticals. Q J Nucl Med 2002; 46:224–232.

    PubMed  Google Scholar 

  8. Maisey M. Is PET the future of nuclear medicine? For. Eur J Nucl Med Mol Imaging 2003; 30:1045–1046.

    Article  PubMed  Google Scholar 

  9. Bailey DL. Is PET the future of nuclear medicine? Against. Eur J Nucl Med Mol Imaging 2003; 30:1046–1049.

    Google Scholar 

  10. Alberto R, Schibli R, Egli A, Schubiger AP. A novel organometallic aqua complex of technetium for the labeling of biomolecules: synthesis of [99mTc(OH2)3(CO)3]+ from [99mTcO4]- in aqueous solution and its reaction with a bifunctional ligand. J Am Chem Soc 1998; 120:7987–7988.

    CAS  Google Scholar 

  11. Buchegger F, Bonvin F, Kosinski M, Schaffland AO, Prior J, Reubi JC, Bläuenstein P, Tourwé D, García-Garayoa E, Bischof-Delaloye A. Radiolabeled neurotensin analog. 99mTc-NT-XI, evaluated in ductal pancreatic adenocarcinoma patients. J Nucl Med 2003; 44:1649–1654.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to James R. Ballinger.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ballinger, J.R., Cooper, M.S. & Mather, S.J. Re: Controversies—[Tc(CO)3]+ chemistry: a promising new concept for SPET?. Eur J Nucl Med Mol Imaging 31, 304–305 (2004). https://doi.org/10.1007/s00259-003-1374-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-003-1374-z

Keywords

Navigation